The primary objective of this trial is to evaluate the long-term safety of BI 695500 in adult patients with moderately to severely active rheumatoid arthritis (RA) who have successfully completed treatment in Trial 1301.1.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01955733?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30
